Kim, Dong Hyun
Im, Sang-Taek
Yoon, Jin Young
Kim, Seunghoon
Kim, Mee Kum
Chung, Myung-Hee
Park, Chul-Kyu
Funding for this research was provided by:
Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2020R1C1C1007372)
Article History
Received: 30 October 2020
Accepted: 12 March 2021
First Online: 25 March 2021
Competing interests
: Dong Hyun Kim is the inventor of the patent for the usage of topical 8-oxo-dG to treat various ocular inflammatory disease. RudaCure company transferred the aforementioned patent of 8-oxo-dG, and Seunghoon Kim is an employee of Rudacure. The rest of the authors have no proprietary interest in this article.